Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
6
×
Tags
biotech
6
×
life sciences
national blog main
san francisco blog main
6
×
boston blog main
deals
fda
national top stories
san francisco top stories
clinical trials
new york blog main
akouos
auris health
cancer
intuitive surgical
ipo
johnson & johnson
national
new york top stories
raleigh-durham blog main
raleigh-durham top stories
roboticsai
san diego blog main
san diego top stories
startups
venture capital
abbvie
alex gorsky
allergan
alnylam pharmaceuticals
amag pharmaceuticals
amunix
anirvan ghosh
armo biosciences
ashley mcevoy
aspire capital fund
astellas pharmaceuticals
astrazeneca
autoimmune
avalon ventures
What
plans
6
×
company
ipo
announced
cash
deal
developing
fda
medical
medicines
acquiring
acquisitions
advance
affects
americans
approved
area
auris
based
bay
billion
bio
biology
biopsy
blood
buildout
builds
buy
cancer
ceo
clearance
close
collabs
company’s
covid
crunch
cytokine
daniel
date
developer
Language
unset
Current search:
plans
×
biotech
×
photo
×
" san francisco blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Titan Medical’s Cash Crunch Stalls Plans to Get Surgical Robot to FDA
@xconomy.com
4 years ago
Liquid Biopsy Firm Lucence Plans Bay Area Buildout With $20M in Tow
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com
5 years ago
Johnson & Johnson to Buy Robotics Startup Auris Health for $3.4B
@xconomy.com
5 years ago
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs